Drugs · acquisition-cost intelligence
antibiotic
Antibiotic Pain Relief· ingredient pramoxineAnesthetics for topical use· NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 [iU]/g; NEOMYCIN SULFATE 3.5 mg/g; POLYMYXIN B SULFATE 10000 [USP'U]/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.09664
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other pramoxine products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| Calaclear | $0.01361 | −$0.08300 |
| Bloop Hemorrhoid Relief Topical | $0.06318 | −$0.03350 |
| hydrocortisone acetate pramoxine HCl | $1.75 | +$1.65 |
| Analpram HC | $3.11 | +$3.02 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.